Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHAD RUOFF

Allopathic & Osteopathic Physicians Internal Medicine Sleep Medicine

NPI
1801031612
CMS profile
471739
Location
SCOTTSDALE, AZ

General Payments · PY2021–2024

$26,544.27

  • Reported across 24 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$14,442.48

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alkermes, Inc. $10,195.86 11
Takeda Pharmaceuticals U.S.A., Inc. $3,842.41 2
JAZZ PHARMACEUTICALS INC. $273.49 2
Respicardia, Inc. $130.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $3,140.00 1
PY2022 $2,721.79 4
PY2023 $6,240.00 3
PY2024 $14,442.48 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $5.11 05/03/2024 Food and Beverage Undisputed 01/23/2026 1120586432 CMS
Alkermes, Inc. $14.80 05/03/2024 Food and Beverage Undisputed 01/23/2026 1120586436 CMS
Alkermes, Inc. $21.39 05/03/2024 Food and Beverage Undisputed 01/23/2026 1120586439 CMS
Alkermes, Inc. $27.30 05/03/2024 Food and Beverage Undisputed 01/23/2026 1120586444 CMS
Alkermes, Inc. $117.48 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1120586448 CMS
Alkermes, Inc. $152.11 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1120586451 CMS
Alkermes, Inc. $158.84 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1120586455 CMS
Alkermes, Inc. $167.53 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1120586459 CMS
Alkermes, Inc. $335.10 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1120586463 CMS
Alkermes, Inc. $646.20 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1120586467 CMS
Alkermes, Inc. $8,550.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 1120586472 CMS
JAZZ PHARMACEUTICALS INC. $182.83 06/02/2024 Food and Beverage Undisputed 01/23/2026 1150232837 CMS
JAZZ PHARMACEUTICALS INC. $90.66 06/02/2024 Food and Beverage Undisputed 01/23/2026 1150232839 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.41 06/04/2024 Food and Beverage Undisputed 01/23/2026 1137665778 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,815.00 06/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1137665780 CMS
ZOLL Respicardia, Inc. $130.72 08/01/2024 Food and Beverage Undisputed 01/23/2026 1146936824 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.